The segment is benefiting from extensive clinical validation and early regulatory approvals from agencies such as the U.S
Picard M, McEwen BS
That may be directly, indirectly through weight loss and improved metabolic health, or as part of a wider positive shift in cardiovascular efficiency
TRIUMPH-3 Retatrutide Results: 22.6% at 12 mg TRIUMPH-3 reported topline results on July 23, 2026 22.6% weight loss at 12 mg over 80 weeks in a cardiovascular-disease population
Adults should aim for 79 hours of quality sleep nightly
Tesamorelin has been shown to increase IGF-1 levels in both men and women, this increase in growth hormone can have various benefits, including improved muscle mass and strength, better sleep quality, improved cognitive function, and enhanced weight loss, particularly in the abdominal area